AnaBios
PrivateLast Round
M&A
Apr 4, 2023
Total Funding Raised
$12.5M
Company Overview
AnaBios is a biotechnology company that provides drug discovery services using its proprietary human-focused translational technologies to establish the safety and efficacy of novel compounds before clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnaBios Comparables
Compare AnaBios with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ncardia | 84% | |
| DefiniGEN | 79% | |
| Revalia Bio | 79% | |
AnaBios Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 4, 2023 | ||||
| Private Equity | Jun 7, 2022 | ||||
| Grant | Sep 30, 2021 | ||||
| Series B | Dec 27, 2016 | ||||
| Series A | Apr 5, 2011 |
Key People
Founding team and executive leadership
AnaBios Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Neurological Disorders and Stroke | Grant |
| TCA Venture Group | Series A |
| Principia SGR | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 118% MoM.
- Nov 8, 2025
Monthly visitors grew 50% MoM, reaching 5.1K.
AnaBios Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AnaBios's valuation, stock price, and market status.